I have been really disappointed by the tardiness of the NIH in this trial. You had a treatment that showed amazing results in patients on deaths door and six months after the first dosing we are not complete on a 300 patient trial.
This was very formally and professionally done by MSB in the CSTN (trial network) with no involvement their end. Meanwhile every other company is out announcing premature and often subsequently failed results (Remdesivir etc). MSB are almost hamstrung by their professional approach, but in the long run results will be unequivocal.
MSB always aimed to be part of a three pronged approach to COViD-19, with vaccines and anti-virals. The tortoise will ultimately end up beating the hares in that race, that we must hope all end up winners in with 1,500+ dying a day in the US alone.
Moderna, page-26
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.19 |
Change
0.085(7.69%) |
Mkt cap ! $1.358B | |||
| Open | High | Low | Value | Volume |
| $1.10 | $1.20 | $1.09 | $13.21M | 11.37M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15000 | $1.19 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.19 | 75212 | 5 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |